SC Filed 2019-04-24 Event — SEC 0001144204-19-020958 →

RA CAPITAL MANAGEMENT, LLC → KalVista Pharmaceuticals, Inc. KALV

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

4 transactions

0 buys · 0 sales · 4 awards/exercises

Issuer Cluster

7 13D/G filings on this issuer

6 other filings besides this one

Filer Track Record

35 filings by this filer

34 other filings in the data moat

Short Interest · settle 2026-03-31

DTC 15.92

20,359,503 shares short · +4.8% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $36.88M

Point72 Asset Mgmt

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-04-16	Piekos Brian	officer	Option exercise	6,250	—	—
2026-04-16	Audhya Paul K.	officer	Option exercise	6,250	—	—
2026-04-16	Sweeny Nicole	officer	Option exercise	6,250	—	—
2026-04-16	Palleiko Benjamin L	director, officer	Option exercise	20,312	—	—

Other 13D/G Filings on KalVista Pharmaceuticals, Inc.

Filed	Form	Filer	Stake	Shares
2024-04-01	SC	TCG Crossover GP I, LLC	—	—	view →
2022-02-10	SC	Longwood Fund II, L.P.	—	—	view →
2021-02-16	SC	SVLSF IV, LLC	—	—	view →
2019-04-15	SC	RA CAPITAL MANAGEMENT, LLC	—	—	view →
2019-04-03	SC	SVLSF IV, LLC	—	—	view →
2019-03-20	SC	SVLSF IV, LLC	—	—	view →

Other Filings by RA CAPITAL MANAGEMENT, LLC

Filed	Form	Issuer	Stake	Shares
2026-01-09	SCHEDULE	Cidara Therapeutics, Inc.	—	—	view →
2025-03-17	SCHEDULE	Mineralys Therapeutics, Inc. MLYS	9.90%	6,287,597	view →
2025-03-10	SCHEDULE	Janux Therapeutics, Inc. JANX	19.90%	11,971,377	view →
2025-03-03	SCHEDULE	89bio, Inc.	13.70%	20,013,733	view →
2025-02-21	SCHEDULE	Solid Biosciences Inc. SLDB	9.90%	7,989,820	view →
2025-02-03	SCHEDULE	89bio, Inc.	15.10%	20,013,733	view →
2024-10-01	SC	Wave Life Sciences Ltd. WVE	—	—	view →
2024-07-01	SC	Eliem Therapeutics, Inc. CLYM	—	—	view →
2024-01-11	SC	Solid Biosciences Inc. SLDB	—	—	view →
2022-07-06	SC	89bio, Inc.	—	—	view →
2022-05-25	SC	Kala Pharmaceuticals, Inc. KALA	—	—	view →
2022-04-01	SC	Kala Pharmaceuticals, Inc. KALA	—	—	view →
2022-03-14	SC	Cytek Biosciences, Inc. CTKB	—	—	view →
2022-02-28	SC	Cytek Biosciences, Inc. CTKB	—	—	view →
2021-11-12	SC	Wave Life Sciences Ltd. WVE	—	—	view →
2021-09-14	SC	POINT Biopharma Global Inc.	—	—	view →
2021-09-13	SC	Acumen Pharmaceuticals, Inc. ABOS	—	—	view →
2021-08-18	SC	Wave Life Sciences Ltd. WVE	—	—	view →
2021-06-16	SC	Werewolf Therapeutics, Inc. HOWL	—	—	view →
2021-06-07	SC	Connect Biopharma Holdings Ltd CNTB	—	—	view →

Showing 20 of 34

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →